A call for a huge cultural and technology shift in the world of drug development

There is a tide of change in drug safety within the pharmaceutical industry.  Internal and external forces are pushing drug safety to expand its scope of operations; from post marketing safety monitoring to a much more active stance in the characterisation of safety profiles during the development of new drugs.  Taking drug safety operations from the reactive approach that dominates the industry to an approach that is more proactive will result in greater safety input during drug development.  This has to be the right direction as drugs are now omnipresent in all facets of our lives.  However, this does call for a huge cultural and technology shift in the world of drug development.

To read the article in full please click on the pdf link below:

Tide of Change in Drug Safety

For further information please contact Kate Adams at kate.adams@wcigroup.com